William Grivas v. Metagenics, Inc. (Case No.: SACV 15-01838-CJC-DFM)
Welcome to the Settlement website for the William Grivas v. Metagenics, Inc. (Case No.: SACV 15-01838-CJC-DFM) Class Action Settlement. This website has been established to provide general information related to this Settlement.

A proposed settlement has been reached in a class action lawsuit. A purchaser of certain Metagenics Medical Food products has sued Metagenics (“Defendant”), alleging that Defendant made false and misleading statements about those products and that they should not have been labelled as “Medical Food.” Defendant denies the Plaintiff’s allegations and any wrongdoing. The Court has not decided which side is right. Instead, the parties have decided to settle the case. The Proposed Settlement creates a $1.3 million settlement fund from which to pay Class Member claims and other costs and expenses related to the litigation and settlement as detailed below.

You are a Class Member and may be eligible to receive money if you purchased any of the following Metagenics products labelled as “Medical Foods” in the United States since November 9, 2011: UltraMeal Plus, UltraMeal Plus 360, UltraGlycemX, and UltraClear.

If you are eligible to participate in this proposed settlement because you purchased one or more of the Products in the United States since November 9, 2011, you can submit a claim for a cash payment from the settlement fund.
Important Dates
  • Exclusion Deadline: March 17, 2019
  • Objection Deadline: March 17, 2019
  • Claims Deadline: April 26, 2019
  • Final Approval Hearing: May 6, 2019 @ 1:30 p.m.
For more information regarding this lawsuit you may click on the Important Documents tab for Court Documents or the Contact Us tab above to obtain contact information for the Claims Administrator.
www.ilymgroupclassaction.com | P.O. Box 2031, Tustin, CA 92871
This website is maintained by ILYM Group, Inc, the Claims Administrator for this settlement. We are a neutral third party engaged to provide information to class members.